Type 2 Diabetes Trial, Recruiting NCT05759637 Sponsor: Istituto Auxologico Italiano Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT05759637
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with type 2 diabetes and obesity

Who may not be able to join:

  • People who are pregnant or breastfeeding
  • People who have sleep apnea
  • People who developed high blood pressure before puberty
  • People who have a hormone-producing growth on their adrenal glands
  • People who have symptoms of too much cortisol (a stress hormone) in their body
  • People who have already been diagnosed with high blood pressure caused by another medical condition
  • People who have conditions known to affect the body's stress hormone system (confirm with trial site)
  • People who have severe autoimmune, rheumatologic, or blood disorders
  • People who have alcoholism
  • People who have kidney disease (specifically, where the kidneys are filtering at less than 60% of normal capacity)
  • People who take medications that affect the body's stress hormone system
  • For one specific group within the trial (Group 2), people who have type 2 diabetes would not be eligible to join that group

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02619112547

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituto Auxologico Italiano
Registry
ClinicalTrials.gov
Start date
6 May 2022
Est. completion
6 December 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Hidden Hypercortisolism prevalence in a sample of T2D patients; Hidden Hypercortisolism prevalence in a sample of Obese patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov